Interactions between the beta-
adrenoceptor agonist
cimaterol and beta-
adrenoceptors on rat skeletal muscle membranes were examined in two studies. In Exp. 1, muscle samples from eight Sprague-Dawley rats (female, approximately 200 g) were used for competition binding and autoradiographic studies using [125I]
cyanopindolol (
ICYP) as a radioligand. The affinities or dissociation constants for binding (KD values) for
cimaterol in plantaris and soleus muscles were .68 and .92 microM, respectively. Muscle areas stained for
succinic dehydrogenase had
propranolol-resistant
ICYP binding sites;
cimaterol did not seem to compete for these sites. In Exp. 2, 60 Sprague-Dawley rats (female, approximately 218 g) were fed 0 or 10 ppm of
cimaterol in rat diet that was ground. Groups were killed after 1, 3, 7, 14, or 28 d of treatment.
Cimaterol increased BW gain up to 14 d after commencement of treatment, with little or no improvement thereafter. Enhanced
weight gain in skeletal muscles also occurred up to 14 d of
cimaterol treatment. Densities of beta-
adrenoceptors in plantaris and soleus muscle membrane homogenates were estimated using a radioligand binding assay with
ICYP. A significant reduction in the number of binding sites (Bmax) was observed after 3 d of
cimaterol treatment in plantaris muscle without a change in the KD of
ICYP binding. The percentage reductions in Bmax were 26.8, 42.2, 37.7, and 37.8% at 3, 7, 14, and 28 d after
cimaterol administration, respectively. In the soleus muscle, significant reductions (44.1 and 29.8%) in Bmax were observed after 3 and 14 d of
cimaterol treatment.(ABSTRACT TRUNCATED AT 250 WORDS)